These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Methylphenidate treatment of attention-deficit/hyperactivity disorder secondary to traumatic brain injury: a critical appraisal of treatment studies. Jin C; Schachar R CNS Spectr; 2004 Mar; 9(3):217-26. PubMed ID: 14999162 [TBL] [Abstract][Full Text] [Related]
5. The Effects of Long-Acting Stimulant and Nonstimulant Medications in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Meta-Analysis of Randomized Controlled Trials. Cerrillo-Urbina AJ; García-Hermoso A; Pardo-Guijarro MJ; Sánchez-López M; Santos-Gómez JL; Martínez-Vizcaíno V J Child Adolesc Psychopharmacol; 2018 Oct; 28(8):494-507. PubMed ID: 29897263 [TBL] [Abstract][Full Text] [Related]
6. Treatment of attention-deficit/hyperactivity disorder. Jadad AR; Boyle M; Cunningham C; Kim M; Schachar R Evid Rep Technol Assess (Summ); 1999 Nov; (11):i-viii, 1-341. PubMed ID: 10790990 [TBL] [Abstract][Full Text] [Related]
7. Evolution of the treatment of attention-deficit/hyperactivity disorder in children: a review. Findling RL Clin Ther; 2008 May; 30(5):942-57. PubMed ID: 18555941 [TBL] [Abstract][Full Text] [Related]
9. Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on Scientific Affairs, American Medical Association. Goldman LS; Genel M; Bezman RJ; Slanetz PJ JAMA; 1998 Apr; 279(14):1100-7. PubMed ID: 9546570 [TBL] [Abstract][Full Text] [Related]
10. Misuse and diversion of stimulants prescribed for ADHD: a systematic review of the literature. Wilens TE; Adler LA; Adams J; Sgambati S; Rotrosen J; Sawtelle R; Utzinger L; Fusillo S J Am Acad Child Adolesc Psychiatry; 2008 Jan; 47(1):21-31. PubMed ID: 18174822 [TBL] [Abstract][Full Text] [Related]
11. An update on central nervous system stimulant formulations in children and adolescents with attention-deficit/hyperactivity disorder. Chavez B; Sopko MA; Ehret MJ; Paulino RE; Goldberg KR; Angstadt K; Bogart GT Ann Pharmacother; 2009 Jun; 43(6):1084-95. PubMed ID: 19470858 [TBL] [Abstract][Full Text] [Related]
13. [Efficacy and safety of stimulants and non-stimulants in adults with attention deficit hyperactivity disorder (ADHD)]. Golubchik P; Sever J; Weizman A Harefuah; 2011 Oct; 150(10):788-90, 814. PubMed ID: 22111124 [TBL] [Abstract][Full Text] [Related]
14. Common and unique therapeutic mechanisms of stimulant and nonstimulant treatments for attention-deficit/hyperactivity disorder. Schulz KP; Fan J; Bédard AC; Clerkin SM; Ivanov I; Tang CY; Halperin JM; Newcorn JH Arch Gen Psychiatry; 2012 Sep; 69(9):952-61. PubMed ID: 22945622 [TBL] [Abstract][Full Text] [Related]
15. The pharmacological and non-pharmacological treatment of attention deficit hyperactivity disorder in children and adolescents: A systematic review with network meta-analyses of randomised trials. Catalá-López F; Hutton B; Núñez-Beltrán A; Page MJ; Ridao M; Macías Saint-Gerons D; Catalá MA; Tabarés-Seisdedos R; Moher D PLoS One; 2017; 12(7):e0180355. PubMed ID: 28700715 [TBL] [Abstract][Full Text] [Related]
16. Comparison of baseline and post-concussion ImPACT test scores in young athletes with stimulant-treated and untreated ADHD. Gardner RM; Yengo-Kahn A; Bonfield CM; Solomon GS Phys Sportsmed; 2017 Feb; 45(1):1-10. PubMed ID: 27736285 [TBL] [Abstract][Full Text] [Related]
17. Is adjunctive pharmacotherapy in attention-deficit/hyperactivity disorder cost-effective in Canada: a cost-effectiveness assessment of guanfacine extended-release as an adjunctive therapy to a long-acting stimulant for the treatment of ADHD. Lachaine J; Sikirica V; Mathurin K BMC Psychiatry; 2016 Jan; 16():11. PubMed ID: 26774811 [TBL] [Abstract][Full Text] [Related]
18. ADHD medication use, adherence, persistence and cost among Texas Medicaid children. Barner JC; Khoza S; Oladapo A Curr Med Res Opin; 2011; 27 Suppl 2():13-22. PubMed ID: 21973228 [TBL] [Abstract][Full Text] [Related]
19. The potential for misuse and abuse of medications in ADHD: a review. Clemow DB; Walker DJ Postgrad Med; 2014 Sep; 126(5):64-81. PubMed ID: 25295651 [TBL] [Abstract][Full Text] [Related]
20. New formulations of stimulants for attention-deficit hyperactivity disorder: therapeutic potential. Connor DF; Steingard RJ CNS Drugs; 2004; 18(14):1011-30. PubMed ID: 15584770 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]